Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1988 1
1989 2
1990 1
1991 5
1992 3
1993 5
1994 5
1995 5
1996 3
1997 3
1998 5
1999 6
2000 6
2001 1
2002 3
2003 2
2004 5
2005 3
2006 5
2007 2
2008 2
2009 7
2010 5
2011 6
2012 3
2013 5
2014 4
2015 2
2016 2
2018 1
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies.
Billoir P, Miranda S, Damian L, Richard V, Benhamou Y, Le Cam Duchez V. Billoir P, et al. Thromb Res. 2018 Sep;169:87-92. doi: 10.1016/j.thromres.2018.07.021. Epub 2018 Jul 17. Thromb Res. 2018. PMID: 30031291
INTRODUCTION: Circulating antiphospholipid antibodies (APL) induce vascular injury and endothelial dysfunction, which are associated with thrombotic events and/or fetal loss. ...Endothelial cells were incubated with the purified anti-beta …
INTRODUCTION: Circulating antiphospholipid antibodies (APL) induce vascular injury and endothelial dysfunction, …
Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors.
Hollerbach A, Müller-Calleja N, Ritter S, Häuser F, Canisius A, Orning C, Jurk K, Lackner KJ. Hollerbach A, et al. Thromb Haemost. 2019 Jul;119(7):1147-1153. doi: 10.1055/s-0039-1685453. Epub 2019 Apr 24. Thromb Haemost. 2019. PMID: 31018220
Antiphospholipid antibodies (aPL) have been reported to activate platelets. ...This extends previous data showing that mTOR is involved in signaling of anti-beta2GPI in monocytes and endothelial cells. In conclusion, anti-beta2GPI aPL activat
Antiphospholipid antibodies (aPL) have been reported to activate platelets. ...This extends previous data showing that
Activation of cultured vascular endothelial cells by antiphospholipid antibodies.
Simantov R, LaSala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE, Silverstein RL. Simantov R, et al. J Clin Invest. 1995 Nov;96(5):2211-9. doi: 10.1172/JCI118276. J Clin Invest. 1995. PMID: 7593607 Free PMC article.
We have demonstrated the activation of cultured human umbilical vein endothelial cells (HUVEC) by IgG from patients with anticardiolipin antibodies (aCL). ...These data support the hypothesis that aPL activate vascular endotheli
We have demonstrated the activation of cultured human umbilical vein endothelial cells (HUVEC) by IgG from patie …
Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factors.
Allen KL, Hamik A, Jain MK, McCrae KR. Allen KL, et al. Blood. 2011 Jun 9;117(23):6383-91. doi: 10.1182/blood-2010-10-313072. Epub 2011 Apr 11. Blood. 2011. PMID: 21482710 Free PMC article.
The majority of APLAs are directed against phospholipid-binding proteins, particularly beta2-glycoprotein I (beta2GPI). Anti-beta2GPI antibodies activate endothelial cells in a beta2GPI-dependent manner through a pathway that involves NF-kappaB. Kruppe …
The majority of APLAs are directed against phospholipid-binding proteins, particularly beta2-glycoprotein I (beta2GPI). Anti-beta2GPI ant
A novel pathway of cellular activation mediated by antiphospholipid antibody-induced extracellular vesicles.
Wu M, Barnard J, Kundu S, McCrae KR. Wu M, et al. J Thromb Haemost. 2015 Oct;13(10):1928-40. doi: 10.1111/jth.13072. Epub 2015 Sep 15. J Thromb Haemost. 2015. PMID: 26264622 Free PMC article.
OBJECTIVE: To determine the mechanism by which EVs released from ECs by anti-beta2 GPI antibodies activate unstimulated ECs. PATIENTS/METHODS: We used interleukin (IL)-1 receptor inhibitors, small interfering RNA (siRNA) against Toll-like receptors (TLRs) and microR …
OBJECTIVE: To determine the mechanism by which EVs released from ECs by anti-beta2 GPI antibodies activate unstimulated ECs. P …
Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies.
Satta N, Kruithof EK, Fickentscher C, Dunoyer-Geindre S, Boehlen F, Reber G, Burger D, de Moerloose P. Satta N, et al. Blood. 2011 May 19;117(20):5523-31. doi: 10.1182/blood-2010-11-316158. Epub 2011 Feb 17. Blood. 2011. PMID: 21330474
The proposed pathogenic mechanisms for aPLA effects include the inflammatory activation of monocytes and endothelial cells. Toll-like receptors (TLRs) are candidate signaling intermediates. ...In HUVECs, inflammatory responses to these aPLAs were increased by …
The proposed pathogenic mechanisms for aPLA effects include the inflammatory activation of monocytes and endothelial cells
Antiphospholipid antibodies prolong the activation of endothelial cells induced by necrotic trophoblastic debris: implications for the pathogenesis of preeclampsia.
Chen Q, Guo F, Hensby-Bennett S, Stone P, Chamley L. Chen Q, et al. Placenta. 2012 Oct;33(10):810-5. doi: 10.1016/j.placenta.2012.07.019. Epub 2012 Aug 16. Placenta. 2012. PMID: 22902008
Antiphospholipid antibodies alone did not active untreated endothelial cells, but did prolong the activation of endothelial cells which had been activated by pre-treatment with necrotic trophoblastic debris. When expo
Antiphospholipid antibodies alone did not active untreated endothelial cells, but did prolong the acti
The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells.
Patterson AM, Ford I, Graham A, Booth NA, Greaves M. Patterson AM, et al. Br J Haematol. 2006 May;133(3):323-30. doi: 10.1111/j.1365-2141.2006.05994.x. Br J Haematol. 2006. PMID: 16643435
The prothrombotic mechanisms associated with antiphospholipid antibodies remain incompletely defined. Antibody binding to endothelial cells in vitro is a feature of antiphospholipid antibody-positive sera. ...We confirmed antibody binding to …
The prothrombotic mechanisms associated with antiphospholipid antibodies remain incompletely defined. Antibody binding to e
Inhibition of the mTORC pathway in the antiphospholipid syndrome.
Canaud G, Bienaimé F, Tabarin F, Bataillon G, Seilhean D, Noël LH, Dragon-Durey MA, Snanoudj R, Friedlander G, Halbwachs-Mecarelli L, Legendre C, Terzi F. Canaud G, et al. N Engl J Med. 2014 Jul 24;371(4):303-12. doi: 10.1056/NEJMoa1312890. N Engl J Med. 2014. PMID: 25054716 Free article.
In cultured vascular endothelial cells, IgG antibodies from patients with the antiphospholipid syndrome stimulated mTORC through the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. Patients with antiphospholipid syndrome nephropa …
In cultured vascular endothelial cells, IgG antibodies from patients with the antiphospholipid syn …
Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies.
Dunoyer-Geindre S, Kruithof EK, Boehlen F, Satta-Poschung N, Reber G, de Moerloose P. Dunoyer-Geindre S, et al. J Thromb Haemost. 2004 Jul;2(7):1176-81. doi: 10.1111/j.1538-7836.2004.00801.x. J Thromb Haemost. 2004. PMID: 15219202 Free article.
BACKGROUND: Antiphospholipid antibodies (APLA) have been shown to activate endothelial cells (EC) in vitro, as documented by an increased expression of tissue factor as well as leukocyte adhesion molecules such as intercellular adhesion molecule …
BACKGROUND: Antiphospholipid antibodies (APLA) have been shown to activate endothelial cells (EC) in vitr …
106 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback